Best TWAS P=2.22e-13 · Best GWAS P=1.21e-12 conditioned to 0.384
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | E2F1 | 0.06 | 0.01 | bslmm | 268 | 0.02 | 1.6e-03 | -6.2 | 6.0 | 2.3e-09 | 0.06 | 0.04 | 0.75 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | UQCC | 0.07 | 0.04 | lasso | 2 | 0.05 | 1.4e-06 | 5.1 | -5.3 | 1.1e-07 | -0.88 | 0.15 | 0.85 | FALSE |
3 | GTEx | Adipose Subcutaneous | UQCC1 | 0.09 | 0.12 | lasso | 2 | 0.11 | 4.5e-09 | 5.5 | -5.5 | 3.9e-08 | -0.90 | 0.92 | 0.08 | FALSE |
4 | GTEx | Adrenal Gland | MMP24-AS1 | 0.18 | 0.04 | enet | 10 | 0.13 | 2.2e-05 | 4.3 | -5.2 | 1.8e-07 | -0.74 | 0.22 | 0.21 | FALSE |
5 | GTEx | Artery Tibial | TP53INP2 | 0.09 | 0.08 | lasso | 1 | 0.07 | 5.6e-06 | 5.7 | 5.7 | 1.2e-08 | 0.06 | 0.01 | 0.98 | TRUE |
6 | GTEx | Artery Tibial | GSS | 0.06 | 0.02 | enet | 25 | 0.04 | 7.7e-04 | 5.7 | 6.5 | 7.1e-11 | 0.35 | 0.29 | 0.09 | FALSE |
7 | GTEx | Brain Hippocampus | E2F1 | 0.39 | 0.25 | lasso | 8 | 0.18 | 4.1e-05 | -6.6 | 6.2 | 5.4e-10 | -0.01 | 0.02 | 0.96 | FALSE |
8 | GTEx | Brain Hypothalamus | E2F1 | 0.26 | 0.02 | lasso | 5 | 0.12 | 9.1e-04 | 3.2 | 6.3 | 2.8e-10 | 0.06 | 0.03 | 0.59 | FALSE |
9 | GTEx | Brain Putamen basal ganglia | E2F1 | 0.18 | 0.22 | lasso | 6 | 0.21 | 1.2e-05 | -6.6 | 6.5 | 9.1e-11 | 0.01 | 0.03 | 0.95 | TRUE |
10 | GTEx | Breast Mammary Tissue (Male) | UQCC1 | 0.06 | 0.04 | lasso | 1 | 0.02 | 1.4e-01 | 5.7 | -5.7 | 1.2e-08 | -0.90 | 0.04 | 0.13 | FALSE |
11 | GTEx | Cells Transformed fibroblasts | UQCC1 | 0.23 | 0.24 | lasso | 8 | 0.25 | 9.4e-19 | 5.5 | -5.2 | 1.9e-07 | -0.88 | 0.97 | 0.03 | FALSE |
12 | GTEx | Esophagus Mucosa | UQCC1 | 0.13 | 0.10 | enet | 10 | 0.07 | 1.1e-05 | 5.7 | -5.6 | 2.3e-08 | -0.89 | 0.44 | 0.55 | FALSE |
13 | GTEx | Lung | UQCC1 | 0.13 | 0.08 | lasso | 5 | 0.06 | 1.0e-05 | 5.5 | -5.4 | 6.1e-08 | -0.90 | 0.45 | 0.55 | FALSE |
14 | GTEx | Nerve Tibial | UQCC1 | 0.07 | 0.04 | enet | 6 | 0.03 | 2.7e-03 | 5.5 | -5.2 | 1.6e-07 | -0.88 | 0.23 | 0.74 | FALSE |
15 | GTEx | Skin Sun Exposed Lower leg | UQCC1 | 0.19 | 0.13 | enet | 16 | 0.10 | 8.1e-09 | 5.5 | -5.3 | 8.6e-08 | -0.84 | 0.96 | 0.04 | FALSE |
16 | GTEx | Stomach | UQCC1 | 0.09 | 0.14 | lasso | 2 | 0.15 | 1.9e-07 | 5.5 | -5.5 | 3.8e-08 | -0.86 | 0.45 | 0.40 | FALSE |
17 | GTEx | Testis | CBFA2T2 | 0.10 | 0.07 | enet | 11 | 0.07 | 6.1e-04 | -6.2 | 6.2 | 7.1e-10 | -0.02 | 0.08 | 0.85 | FALSE |
18 | GTEx | Thyroid | CBFA2T2 | 0.11 | 0.05 | enet | 18 | 0.06 | 2.6e-05 | 3.3 | 5.3 | 1.3e-07 | -0.02 | 0.13 | 0.84 | FALSE |
19 | METSIM | Adipose | UQCC1 | 0.09 | 0.04 | enet | 18 | 0.05 | 1.5e-07 | 5.5 | -5.5 | 4.1e-08 | -0.90 | 0.14 | 0.86 | FALSE |
20 | NTR | Blood | UQCC | 0.01 | 0.01 | enet | 6 | 0.00 | 1.6e-02 | 5.5 | -6.0 | 2.0e-09 | -0.89 | 0.08 | 0.78 | FALSE |
21 | ROSMAP | Brain Pre-frontal Cortex | UQCC1 | 0.05 | 0.05 | lasso | 5 | 0.06 | 1.7e-08 | 5.6 | -6.0 | 1.6e-09 | -0.84 | 0.21 | 0.79 | FALSE |
22 | ROSMAP | Brain Pre-frontal Cortex | GDF5 | 0.10 | 0.13 | lasso | 2 | 0.12 | 2.9e-15 | 5.5 | 5.5 | 3.8e-08 | 0.90 | 0.80 | 0.20 | FALSE |
23 | YFS | Blood | EIF6 | 0.02 | 0.00 | blup | 341 | 0.01 | 4.1e-05 | 4.9 | 5.1 | 3.0e-07 | 0.37 | 0.88 | 0.02 | FALSE |
24 | YFS | Blood | UQCC | 0.21 | 0.19 | lasso | 26 | 0.20 | 6.4e-64 | 5.5 | -5.6 | 2.5e-08 | -0.88 | 0.96 | 0.04 | FALSE |
25 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | UQCC | 0.03 | 0.04 | blup | 67 | 0.03 | 2.6e-03 | 5.5 | -5.9 | 4.2e-09 | -0.91 | 0.02 | 0.91 | FALSE |
26 | The Cancer Genome Atlas | Breast Invasive Carcinoma | GGT7 | 0.02 | 0.02 | lasso | 3 | 0.02 | 2.2e-04 | 5.7 | -5.4 | 7.4e-08 | -0.09 | 0.02 | 0.88 | FALSE |
27 | The Cancer Genome Atlas | Colon Adenocarcinoma | CBFA2T2 | 0.13 | 0.04 | lasso | 1 | 0.03 | 1.1e-02 | -6.4 | 6.4 | 1.6e-10 | 0.01 | 0.01 | 0.68 | FALSE |
28 | The Cancer Genome Atlas | Glioblastoma Multiforme | UQCC | 0.15 | 0.02 | blup | 67 | 0.04 | 2.0e-02 | 2.2 | -5.6 | 2.5e-08 | -0.74 | 0.02 | 0.64 | FALSE |
29 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | CEP250 | 0.02 | 0.01 | blup | 43 | 0.02 | 8.0e-04 | 4.6 | 5.6 | 2.6e-08 | 0.79 | 0.03 | 0.83 | FALSE |
30 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | TRPC4AP | 0.05 | 0.03 | enet | 10 | 0.04 | 7.1e-05 | -4.0 | 5.3 | 1.0e-07 | -0.07 | 0.04 | 0.81 | FALSE |
31 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | UQCC | 0.05 | 0.06 | blup | 66 | 0.06 | 3.6e-07 | 4.4 | -5.4 | 6.9e-08 | -0.87 | 0.13 | 0.87 | FALSE |
32 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | CEP250 | 0.03 | 0.01 | blup | 43 | 0.03 | 2.6e-04 | 7.1 | 5.5 | 4.6e-08 | 0.77 | 0.01 | 0.89 | FALSE |
33 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | UQCC | 0.09 | 0.10 | blup | 67 | 0.10 | 7.2e-11 | 5.4 | -5.3 | 1.1e-07 | -0.88 | 0.94 | 0.06 | FALSE |
34 | The Cancer Genome Atlas | Brain Lower Grade Glioma | CBFA2T2 | 0.02 | 0.01 | blup | 31 | 0.01 | 1.8e-02 | -6.3 | 5.6 | 1.8e-08 | 0.02 | 0.01 | 0.70 | FALSE |
35 | The Cancer Genome Atlas | Brain Lower Grade Glioma | GDF5 | 0.09 | 0.11 | blup | 76 | 0.12 | 1.0e-13 | 5.4 | 5.3 | 1.4e-07 | 0.83 | 0.14 | 0.86 | FALSE |
36 | The Cancer Genome Atlas | Brain Lower Grade Glioma | UQCC | 0.04 | 0.06 | lasso | 6 | 0.05 | 2.3e-06 | 5.5 | -5.5 | 3.5e-08 | -0.90 | 0.64 | 0.36 | FALSE |
37 | The Cancer Genome Atlas | Lung Adenocarcinoma | UQCC | 0.10 | 0.07 | enet | 10 | 0.07 | 1.5e-08 | 5.6 | -5.2 | 1.6e-07 | -0.89 | 0.09 | 0.91 | FALSE |
38 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | MMP24 | 0.04 | 0.04 | blup | 62 | 0.02 | 7.4e-04 | 4.4 | -5.2 | 2.4e-07 | -0.55 | 0.17 | 0.74 | FALSE |
39 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | UQCC | 0.07 | 0.08 | blup | 67 | 0.07 | 1.1e-08 | 5.4 | -5.9 | 3.9e-09 | -0.82 | 0.05 | 0.95 | FALSE |
40 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | GDF5 | 0.05 | 0.02 | blup | 76 | 0.04 | 1.4e-03 | 5.5 | 5.9 | 4.2e-09 | 0.89 | 0.03 | 0.91 | FALSE |
41 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | UQCC | 0.22 | 0.21 | lasso | 7 | 0.18 | 1.9e-07 | 5.3 | -5.6 | 2.0e-08 | -0.84 | 0.31 | 0.69 | FALSE |
42 | The Cancer Genome Atlas | Prostate Adenocarcinoma | GDF5 | 0.05 | 0.05 | lasso | 5 | 0.04 | 7.2e-05 | 7.1 | 6.7 | 1.5e-11 | 0.95 | 0.00 | 1.00 | FALSE |
43 | The Cancer Genome Atlas | Prostate Adenocarcinoma | UQCC | 0.07 | 0.10 | lasso | 8 | 0.11 | 1.3e-11 | 5.4 | -5.6 | 2.3e-08 | -0.90 | 0.36 | 0.64 | FALSE |
44 | The Cancer Genome Atlas | Soft Tissue Sarcoma | UQCC | 0.07 | 0.06 | blup | 66 | 0.07 | 5.2e-05 | 5.5 | -5.8 | 8.3e-09 | -0.89 | 0.02 | 0.97 | FALSE |
45 | The Cancer Genome Atlas | Stomach Adenocarcinoma | GDF5 | 0.09 | 0.04 | enet | 13 | 0.05 | 2.4e-04 | 7.1 | 7.3 | 2.2e-13 | 0.85 | 0.00 | 0.99 | TRUE |
46 | The Cancer Genome Atlas | Thyroid Carcinoma | CEP250 | 0.05 | 0.03 | blup | 43 | 0.04 | 5.8e-05 | 4.5 | 5.7 | 1.6e-08 | 0.78 | 0.12 | 0.83 | FALSE |
47 | The Cancer Genome Atlas | Thyroid Carcinoma | GDF5 | 0.02 | 0.00 | blup | 76 | 0.00 | 1.9e-01 | 5.7 | 5.4 | 5.9e-08 | 0.90 | 0.02 | 0.88 | FALSE |
48 | The Cancer Genome Atlas | Thyroid Carcinoma | UQCC | 0.15 | 0.21 | blup | 67 | 0.22 | 1.2e-20 | 5.7 | -5.8 | 6.4e-09 | -0.88 | 0.49 | 0.51 | FALSE |